Thomas Richard Kassberg insider trades

Open-market stock purchases and sales by Thomas Richard Kassberg, Unknown at Passage BIO, Inc, from SEC Form 4 filings since Jan 30, 2014.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
May 19, 2026PASG Passage BIO, IncBought (not open market)—

Companies traded

  • PASG Passage BIO, Inc: other filings, last May 19, 2026
  • RARE Ultragenyx Pharmaceutical Inc: 1 buy, 26 sales, last Mar 3, 2025

Get free alerts when Thomas Richard Kassberg files a new trade →